Literature DB >> 12165168

Methods for quantifying self-monitoring blood glucose profiles exemplified by an examination of blood glucose patterns in patients with type 1 and type 2 diabetes.

Boris P Kovatchev1, Daniel J Cox, Linda Gonder-Frederick, William L Clarke.   

Abstract

The maintenance of glycemic control in patients with type 1 or type 2 diabetes mellitus (T1DM and T2DM, respectively) is commonly assisted by devices for self-monitoring of blood glucose (SMBG) that store multiple BG determinations. However, besides average BG, no other SMBG characteristics are routinely computed. We describe several SMBG-based measures that quantify the extent and rate of patients' BG excursions into hypoglycemia and hyperglycemia and can be used as markers for patients' vulnerability to hypoglycemia and BG irregularity. These markers are applied to analyze data from patients with T1DM (n = 277) and T2DM (n = 323), all of whom used insulin. T1DM and T2DM patients were matched by HbA(1c), gender, and number of SMBG readings/day. On average, 230 SMBG readings and three HbA(1c) assays were collected for each subject over 3 months. Compared with T2DM, patients with T1DM diabetes had (1) more extreme low and high BGs, (2) greater risk for severe hypoglycemia as quantified by the Low BG Index, (3) faster descent into hypoglycemia as quantified by the risk rate of change/hour, and (4) greater BG irregularity as computed by BG rate of change/hour and BG SD (all p levels < 0.0001). SMBG data allow for computing and frequent updating of various idiosyncratic diabetes characteristics and risk factors. The use of such computations may assist in optimizing patients' glycemic control.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12165168     DOI: 10.1089/152091502760098438

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  27 in total

1.  Development of a multi-parametric model predictive control algorithm for insulin delivery in type 1 diabetes mellitus using clinical parameters.

Authors:  M W Percival; Y Wang; B Grosman; E Dassau; H Zisser; L Jovanovič; F J Doyle
Journal:  J Process Control       Date:  2011-03-01       Impact factor: 3.666

Review 2.  Measures of glycemic variability and links with psychological functioning.

Authors:  Joseph R Rausch
Journal:  Curr Diab Rep       Date:  2010-12       Impact factor: 4.810

3.  Are Risk Indices Derived From CGM Interchangeable With SMBG-Based Indices?

Authors:  Chiara Fabris; Stephen D Patek; Marc D Breton
Journal:  J Diabetes Sci Technol       Date:  2015-08-14

4.  Statistical tools to analyze continuous glucose monitor data.

Authors:  William Clarke; Boris Kovatchev
Journal:  Diabetes Technol Ther       Date:  2009-06       Impact factor: 6.118

5.  Pramlintide reduces the risks associated with glucose variability in type 1 diabetes.

Authors:  Boris P Kovatchev; John Crean; Anthony McCall
Journal:  Diabetes Technol Ther       Date:  2008-10       Impact factor: 6.118

6.  Peculiarities of the continuous glucose monitoring data stream and their impact on developing closed-loop control technology.

Authors:  Boris Kovatchev; William Clarke
Journal:  J Diabetes Sci Technol       Date:  2008-01

7.  Use of fourier models for analysis and interpretation of continuous glucose monitoring glucose profiles.

Authors:  Michael Miller; Poul Strange
Journal:  J Diabetes Sci Technol       Date:  2007-09

8.  Optimum subcutaneous glucose sampling and fourier analysis of continuous glucose monitors.

Authors:  Marc D Breton; Devin P Shields; Boris P Kovatchev
Journal:  J Diabetes Sci Technol       Date:  2008-05

9.  Evaluating the efficacy of closed-loop glucose regulation via control-variability grid analysis.

Authors:  Lalo Magni; Davide M Raimondo; Chiara Dalla Man; Marc Breton; Stephen Patek; Giuseppe De Nicolao; Claudio Cobelli; Boris P Kovatchev
Journal:  J Diabetes Sci Technol       Date:  2008-07

10.  Enhanced Model Predictive Control (eMPC) Strategy for Automated Glucose Control.

Authors:  Joon Bok Lee; Eyal Dassau; Ravi Gondhalekar; Dale E Seborg; Jordan E Pinsker; Francis J Doyle
Journal:  Ind Eng Chem Res       Date:  2016-10-27       Impact factor: 3.720

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.